Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021

Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021




Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021

EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report second quarter 2021 financial results on Monday, August 9, after market close. Subsequently, Adamas’ management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update.

Investor Conference Call and Webcast

The conference call can be accessed by dialing 1-877-407-9716 for participants in the U.S. or Canada and 1-201-493-6779 for international callers. All callers must provide the following Conference ID: 13720109. The webcast can be accessed live via the investor section of the Adamas website at https://ir.adamaspharma.com/events-presentations and will be available for replay for approximately 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Contacts

Media:
Sarah Mathieson

Vice President of Corporate Communications

510-450-3528

smathieson@adamaspharma.com

Investors:

Peter Vozzo

Managing Director, Westwicke

443-213-0505

peter.vozzo@westwicke.com